Unsplash / Public Domain / Mitch Nielsen
Investing in pot stocks is being called the gold rush of the 21st century. That’s because sales skyrocketed to $6.7 billion in North America in 2016, and sales are only going to increase as more states legalize recreational and medical marijuana.
Forward-thinking investors are already plotting seven-figure weed windfalls with the top pot stocks from every ecosystem.
And the first stock on our marijuana watch list has already climbed more than 100% so far in 2017.
The combination of cannabinoids and chemotherapy could be the key to improving cancer treatment. This is according to a new study published in the International Journal of Oncology on May 29, 2017.
On June 5, 2017, Colorado Gov. John Hickenlooper signed Senate Bill 17, approving post-traumatic stress disorder as a qualifying condition for the state’s medical marijuana program. With the addition of Colorado, there are now 20 states, plus Washington, D.C., that allow medical marijuana for PTSD.
In an attempt to gain a foothold in Massachusetts’ burgeoning recreational marijuana industry, the tobacco industry wants marijuana producers to distribute their products through its members.
